- Home
- ALLR vs AMS Comparison
ALLR vs AMS Comparison
Compare ALLR & AMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLR
- AMS
- Stock Information
- Founded
- ALLR 2004
- AMS 1980
- Country
- ALLR United States
- AMS United States
- Employees
- ALLR N/A
- AMS N/A
- Industry
- ALLR Biotechnology: Pharmaceutical Preparations
- AMS Medical Specialities
- Sector
- ALLR Health Care
- AMS Health Care
- Exchange
- ALLR Nasdaq
- AMS Nasdaq
- Market Cap
- ALLR 15.8M
- AMS 18.3M
- IPO Year
- ALLR N/A
- AMS N/A
- Fundamental
- Price
- ALLR $1.01
- AMS $2.47
- Analyst Decision
- ALLR
- AMS
- Analyst Count
- ALLR 0
- AMS 0
- Target Price
- ALLR N/A
- AMS N/A
- AVG Volume (30 Days)
- ALLR 417.1K
- AMS 16.8K
- Earning Date
- ALLR 08-04-2025
- AMS 08-13-2025
- Dividend Yield
- ALLR N/A
- AMS N/A
- EPS Growth
- ALLR N/A
- AMS 151.01
- EPS
- ALLR N/A
- AMS 0.21
- Revenue
- ALLR N/A
- AMS $29,236,000.00
- Revenue This Year
- ALLR N/A
- AMS $23.63
- Revenue Next Year
- ALLR N/A
- AMS N/A
- P/E Ratio
- ALLR N/A
- AMS $11.63
- Revenue Growth
- ALLR N/A
- AMS 35.25
- 52 Week Low
- ALLR $0.61
- AMS $2.27
- 52 Week High
- ALLR $7.45
- AMS $4.60
- Technical
- Relative Strength Index (RSI)
- ALLR 53.22
- AMS 52.84
- Support Level
- ALLR $0.95
- AMS $2.44
- Resistance Level
- ALLR $1.08
- AMS $3.02
- Average True Range (ATR)
- ALLR 0.07
- AMS 0.13
- MACD
- ALLR 0.01
- AMS 0.02
- Stochastic Oscillator
- ALLR 59.39
- AMS 29.33
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.
About AMS American Shared Hospital Services
American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy, and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.